Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BridgeBio Pharma Q3 EPS $(0.95) Misses $(0.89) Estimate, Sales $120.700M Beat $106.386M Estimate

Author: Benzinga Newsdesk | October 29, 2025 03:02pm
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.89) by 7.1 percent. This is a 10.47 percent decrease over losses of $(0.86) per share from the same period last year. The company reported quarterly sales of $120.700 million which beat the analyst consensus estimate of $106.386 million by 13.45 percent. This is a 4.32K percent increase over sales of $2.732 million the same period last year.

Posted In: BBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist